Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer

Despite recent advances in colorectal cancer (CRC) treatment, a large proportion of patients show limited responses to therapies, especially in advanced stages. There is an urgent need to identify prognostic biomarkers and/or therapeutic targets in advanced stages, aiming to improve the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleh, Reem, Taha, Rowaida Z., Toor, Salman M., Sasidharan Nair, Varun, Murshed, Khaled, Khawar, Mahwish, Al-Dhaheri, Mahmood, Petkar, Mahir Abdulla, Abu Nada, Mohamed, Elkord, Eyad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511277/
https://www.ncbi.nlm.nih.gov/pubmed/32393998
http://dx.doi.org/10.1007/s00262-020-02593-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511277/
https://www.ncbi.nlm.nih.gov/pubmed/32393998
http://dx.doi.org/10.1007/s00262-020-02593-w

Ejemplares similares